Research Roundup

Debbie Rigby rounds up the latest in research news Harms and benefits of sodium‑glucose co‑transporter 2 inhibitors Sodium-glucose co-transporter 2 inhibitors are oral glucose-lowering drugs that increase the urinary excretion of glucose. In patients with type 2 diabetes and cardiovascular disease they reduce all-cause mortality, cardiac mortality, rates of hospitalisation for heart failure and the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Nice Fro Bro
Next Vector-borne disease: take a bigger role